3',4'-Dihydroxyflavone mitigates inflammatory responses by inhibiting LPS and TLR4/MD2 interaction

Phytomedicine. 2023 Jan:109:154553. doi: 10.1016/j.phymed.2022.154553. Epub 2022 Nov 17.

Abstract

Background: We previously reported the potential inhibitory activity of 3',4'-dihydroxyflavone (DHF) on nitric oxide (NO) and prostaglandin E2 (PGE2) production in lipopolysaccharide (LPS)-stimulated macrophages.

Purpose: We investigated the underlying molecular mechanisms of DHF in LPS-activated macrophages and evaluated its effect on LPS-induced septic shock in mice.

Methods: To explore the anti-inflammatory effect of DHF, nitrite, PGE2, and cytokines were measured in vitro and in vivo experiments. In addition, to verify the molecular signaling pathway, quantitative real time-PCR, luciferase assay, nuclear extraction, electrophoretic mobility shift assay, immunocytochemistry, immunoprecipitation, molecular docking analysis, and myeloid differentiation 2 (MD2)-LPS binding assay were conducted.

Results: DHF suppressed the LPS-induced expression of proinflammatory mediators through nuclear factor-κB (NF-κB), activator protein-1 (AP-1), and interferon regulatory factor 3 (IRF3) inactivation pathways in RAW 264.7 macrophages. Importantly, molecular docking analysis and in vitro binding assays showed that DHF interacts with the hydrophobic pocket of MD2 and then interferes with the interaction between LPS and toll-like receptor 4 (TLR4). DHF inhibited LPS-induced oxidative stress by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2). Treatment of LPS-induced endotoxemia mice with DHF reduced the expression levels of pro-inflammatory mediators via the inactivation of NF-κB, AP-1, and signal transducer and activator of transcription 1 (STAT1) in the lung tissue, thus increasing the survival rate.

Conclusion: Taken together, our data first time revealed the underlying mechanism of the DHF-dependent anti-inflammatory effect by preventing LPS from binding to the TLR4/MD2 complex. Therefore, DHF may be a possible anti-inflammatory agent for the treatment of LPS-mediated inflammatory diseases.

Keywords: 3´,4´-Dihydroxyflavone; Anti-inflammation; MD2; Macrophage; Septic shock; TLR4.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Lipopolysaccharides* / pharmacology
  • Mice
  • Molecular Docking Simulation
  • NF-kappa B* / metabolism
  • Toll-Like Receptor 4 / metabolism
  • Transcription Factor AP-1 / metabolism

Substances

  • Lipopolysaccharides
  • NF-kappa B
  • Toll-Like Receptor 4
  • Transcription Factor AP-1
  • 3',4'-dihydroxyflavone
  • Anti-Inflammatory Agents
  • Tlr4 protein, mouse